Skip to main content
. 2018 Apr 17;105(9):1200–1209. doi: 10.1002/bjs.10822

Fig. 2.

Fig. 2

a Recurrence-free survival and b overall survival in patients who did not undergo perihepatic lymphadenectomy and in patients who had lymphadenectomy with or without identification of perihepatic lymph node metastases (PLNMs). c Overall survival according to location of PLNMs. d Overall survival in patients with PLNMs according to number of metastases. aP = 0·542 (no lymphadenectomy versus lymphadenectomy without PLNMs), P < 0·001 (no lymphadenectomy versus lymphadenectomy with PLNMs), P < 0·001 (lymphadenectomy with versus without PLNMs); bP = 0·030 (no lymphadenectomy versus lymphadenectomy without PLNMs), P < 0·001 (no lymphadenectomy versus lymphadenectomy with PLNMs), P < 0·001 (lymphadenectomy with versus without PLNMs); cP = 0·012 (PLNMs along hepatoduodenal ligament versus para-aortic PLNMs), dP = 0·039 (log rank test)